MedTrace Logo

Validation of a Noninvasive Automated Blood Pressure Device

NCT03566888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2018-11-08

No results posted yet for this study

Summary

The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.

Conditions

  • Blood Pressure

Interventions

DEVICE

Blood pressure assessment

Validation of an automated blood pressure device

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Todd Schroeder, PhD · University of Southern California

Eligibility

Min Age
12 Years
Max Age
92 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-10-02
Completion
2018-10-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03566888 on ClinicalTrials.gov